EGFR and breast carcinoma: In the transgenic mouse model whey acidic protein-transforming growth factor α (WAP-TGFα), which develops EGFR-dependent mammary carcinomas, 1/3 of animals showed partial regression, 1/3 no progression and 1/3 demonstrated a complete regression with no observable tumor upon necropsy.